Banyan Biomarkers - Product Pipeline Analysis, 2013 Update - New Market Research Report

Banyan Biomarkers (Banyan) is a research and development company. It develops and markets biomarker diagnostic tests for the healthcare markets. Banyan creates point of care blood test to diagnose traumatic brain injury. The company offers biomarkers for traumatic brain injuries and strokes, psychiatric disorders, neuroinflammation, apoptosis, necrosis, and liver injuries. It provides biomarkers for stroke, Alzheimer's disease, Parkinson's and Huntington's disease, and depression; and therapeutic candidates for neuro-protection. The company serves pharmaceutical companies, biotechnology companies, and investigators at academic research institutes. The company provides primary neuronal culture models of neuroinjury and neurotoxicity, including cerebrocortical cultures, cerebellum granule neurons, and hippocampal neurons; protease enzyme assays; cell-based protease assays; and others. Banyan is headquartered in Alachua, Florida, the US.

Full Report Details at
- http://www.fastmr.com/prod/606021_banyan_biomarkers_product_pipeline_analysis_2013.aspx?afid=301

This report is a source for data, analysis and actionable intelligence on the Banyan Biomarkers portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

* Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
* Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
* Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
* Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
* Data on relevant clinical trials and product patent details, wherever applicable.
* Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get this Report

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Epistem Holdings Plc (EHP) - Product Pipeline Analysis, 2013 Update
- Randox Laboratories Ltd. - Product Pipeline Analysis, 2013 Update
- Digna Biotech, S.L. - Product Pipeline Analysis, 2013 Update
- GE Healthcare - Product Pipeline Analysis , 2013 Update
- Oxford Gene Technology - Product Pipeline Analysis, 2013 Update